Compare · BOWN vs KVUE
BOWN vs KVUE
Side-by-side comparison of Bowen Acquisition Corp (BOWN) and Kenvue Inc. (KVUE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BOWN and KVUE operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- KVUE has hit the wire 43 times in the past 4 weeks while BOWN has been quiet.
- KVUE has more recent analyst coverage (25 ratings vs 0 for BOWN).
- Company
- Bowen Acquisition Corp
- Kenvue Inc.
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NASDAQ
- NYSE
- IPO
- 2023
- 2023
- News (4w)
- 0
- 43
- Recent ratings
- 0
- 25
Latest BOWN
- SEC Form NT 10-Q filed by Bowen Acquisition Corp
- SEC Form PRE 14A filed by Bowen Acquisition Corp
- Bowen Acquisition Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 10-Q filed by Bowen Acquisition Corp
- SEC Form NT 10-Q filed by Bowen Acquisition Corp
- Amendment: SEC Form SCHEDULE 13G/A filed by Bowen Acquisition Corp
- Bowen Acquisition Corp filed SEC Form 8-K: Financial Statements and Exhibits
- Bowen Acquisition Corp Receives NASDAQ Delisting Notification for Failure to Comply with Listing Requirements
- Nasdaq Halts Bowen Acquisition Corp.
- Bowen Acquisition Corp filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest KVUE
- FDA Approval for WOMEN'S ROGAINE issued to KENVUE BRANDS
- FDA Approval for MEN'S ROGAINE issued to KENVUE BRANDS
- FDA Approval for ROGAINE (FOR MEN) issued to KENVUE BRANDS
- FDA Approval for ROGAINE (FOR WOMEN) issued to KENVUE BRANDS
- FDA Approval for ROGAINE EXTRA STRENGTH (FOR MEN) issued to KENVUE BRANDS
- SEC Form 15-12G filed by Kenvue Inc.
- SEC Form EFFECT filed by Kenvue Inc.
- Chief Tech & Data Officer Wondrasch Michael returned 45,453 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Scientific Officer Tillett Caroline returned 77,709 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Operations Officer Stevens Meredith returned 114,183 shares to the company, closing all direct ownership in the company (SEC Form 4)